Hermetica Superfood Encyclopedia
The Short Answer
Justicia gendarussa leaves contain flavonoids (quercetin, apigenin, vitexin), phenolic acids, arylnaphthalide lignan glycosides (justiprocumins A and B), and terpenoids that exert antioxidant, anti-inflammatory, and antimicrobial effects via free radical scavenging, membrane disruption, and inhibition of viral replication. In rat hepatoprotection models, a 300 mg/kg methanolic leaf extract reduced total bilirubin by 73.71%, a result comparable to the reference hepatoprotectant silymarin, though no human clinical trials have yet confirmed these effects.
CategoryHerb
GroupSoutheast Asian
Evidence LevelPreliminary
Primary KeywordJusticia gendarussa benefits
Gandarussa — botanical close-up
Health Benefits
**Hepatoprotection**
Methanolic leaf extracts at 300 mg/kg reduced total bilirubin by 73.71% and direct bilirubin by 31.70% in experimentally induced liver injury in rats, performance comparable to silymarin, mediated by the antioxidant and membrane-stabilizing actions of quercetin and polyphenols.
**Anti-inflammatory Activity**
Methanolic extracts demonstrated 76% membrane stabilization in in vitro red blood cell lysis assays, a validated proxy for anti-inflammatory potency, attributed to phenolic compounds modulating arachidonic acid and oxidative stress pathways.
**Antimicrobial Efficacy**
Leaf extracts exhibited zones of inhibition of 15–16 mm against Staphylococcus aureus, Candida albicans, and Shigella flexneri, with minimum inhibitory concentrations (MICs) ranging from 8 to 2,048 µg/mL depending on solvent and organism, driven by membrane-disrupting terpenoids and saponins.
**Antioxidant Capacity**
Methanolic extracts yielded total phenolic content of 280.41 ± 0.58 mg gallic acid equivalents per gram and flavonoid content of 165.52 ± 0.65 mg quercetin equivalents per gram, conferring potent free radical scavenging activity relevant to oxidative stress-related conditions.
**Anti-HIV Potential**
Bioassay-directed isolation from methanolic stalk and bark extracts identified justiprocumins A and B, novel arylnaphthalide lignan glycosides that inhibit HIV replication in cell-based assays, representing a structurally distinct class of antiviral scaffold.
**Antipyretic and Antirheumatic Use**
Traditional Jamu practice employs leaf decoctions for fevers and rheumatic pain, uses corroborated by the anti-inflammatory phenolic profile, though controlled pharmacological studies specifically addressing fever reduction or joint inflammation are currently lacking.
**Antifungal Activity**
Aqueous and methanolic leaf extracts inhibit Candida albicans growth with measurable zones of inhibition (15 mm for methanolic extract), suggesting saponins and flavonoids contribute to disruption of fungal membrane integrity.
Origin & History
Natural habitat
Justicia gendarussa is native to tropical Asia, with its primary range spanning India, Indonesia, Malaysia, and the Philippines, where it grows as a shrub in humid lowland forests, roadsides, and cultivated gardens up to 1,000 m elevation. In Indonesia, it is a cornerstone plant of the traditional Jamu herbal medicine system, cultivated around village homesteads for ready medicinal access. The plant thrives in well-drained, moist soils under partial shade and is propagated by stem cuttings, reflecting centuries of deliberate horticultural selection by indigenous communities.
“Justicia gendarussa has been embedded in Southeast Asian ethnomedicine for centuries, appearing in classical Javanese and Balinese herbal manuscripts as a treatment for rheumatism, muscle pain, contusions, and febrile illness, often applied as both a topical poultice and an oral decoction. In Indonesian Jamu tradition—one of the world's oldest documented herbal medicine systems—gandarussa leaves are combined with other botanicals such as ginger and turmeric to create compound remedies for joint pain and postpartum recovery. The plant holds additional ethnobotanical significance in Papua New Guinea, where male community members have historically consumed leaf preparations as a male contraceptive, a use that attracted international research interest in the late 20th century. Its Sanskrit-derived name variants and mention in Ayurvedic texts suggest trans-regional medicinal knowledge exchange across maritime Southeast Asia and the Indian subcontinent predating modern documentation.”Traditional Medicine
Scientific Research
The current evidence base for Justicia gendarussa consists exclusively of in vitro phytochemical studies, GC-MS and HPLC compositional analyses, and small uncontrolled animal experiments; no peer-reviewed human clinical trials have been published. Hepatoprotection data derive from rat studies of unspecified sample size using carbon tetrachloride or paracetamol-induced liver injury models, reporting 73.71% total bilirubin reduction at 300 mg/kg—promising but not transferable to human dosing without pharmacokinetic bridging studies. Antimicrobial findings are based on standard disc diffusion and broth microdilution assays conducted in vitro, providing mechanistic plausibility but no infection-resolution endpoints in living organisms. The overall evidence quality is preclinical, with significant gaps in standardized extract characterization, reproducibility across independent laboratories, and any dose-response or safety data in human subjects.
Preparation & Dosage
Traditional preparation
**Traditional Leaf Decoction (Jamu)**
10–15 g) boiled in 300–500 mL of water for 15–20 minutes, strained, and consumed once or twice daily for fever, rheumatism, or inflammation—the predominant form in Indonesian traditional medicine
Fresh or dried leaves (approximately .
**Methanolic Extract (Research Grade)**
150–500 mg/kg body weight, with peak hepatoprotective effects observed at 300 mg/kg; no validated human equivalent dose has been established
Used in animal studies at .
**Aqueous Extract**
Used in antimicrobial assays; preparation involves cold maceration or hot infusion of dried leaf powder in distilled water; MICs vary widely (8–2,048 µg/mL by pathogen).
**Ethanolic Extract**
41 mg GAE/g) and flavonoid (165
Employed in phytochemical and antioxidant studies; yields the highest phenolic (280..52 mg QE/g) content relative to aqueous preparations.
**Standardization**
No commercial standardization to specific marker compounds (quercetin, apigenin, or justiprocumins) exists; any future supplement would require HPLC-based fingerprinting.
**Timing**
Traditional use does not specify timing relative to meals; pharmacological studies do not address circadian or prandial effects on absorption.
Nutritional Profile
Justicia gendarussa leaves are not consumed as a dietary staple and possess no established macronutrient profile of nutritional significance. Phytochemically, methanolic leaf extracts are rich in total phenolics (280.41 ± 0.58 mg gallic acid equivalents per gram dry extract) and total flavonoids (165.52 ± 0.65 mg quercetin equivalents per gram dry extract), among the highest reported for Acanthaceae species. GC-MS profiling identifies fatty acid components including hexadecanoic acid (8.11% peak area), octadecenoic acid (8.41%), hepta-9,10,11-trienoic acid (17.43%), and the dominant eicosane aldehyde (37.56%), alongside the polyol 1,3,4,5-tetrahydroxycyclohexanecarboxylic acid as a major polar constituent. Bioavailability of these compounds in humans is unknown; lipophilic flavonoid aglycones (quercetin, apigenin) are expected to have moderate intestinal absorption, while glycosides such as vitexin require gut microbial deglycosylation prior to absorption, a process that varies substantially by individual microbiome composition.
How It Works
Mechanism of Action
Flavonoids quercetin, apigenin, and vitexin exert antioxidant effects primarily through hydrogen atom transfer and single electron transfer mechanisms that neutralize reactive oxygen species, thereby reducing oxidative hepatocellular damage and lipid peroxidation at the cellular membrane level. Phenolic compounds, including gallic acid derivatives identified by FTIR and HPLC, likely modulate NF-κB and COX-2 inflammatory signaling pathways, providing a mechanistic basis for the observed 76% membrane stabilization in erythrocyte lysis assays. Arylnaphthalide lignan glycosides justiprocumins A and B are proposed to interfere with HIV reverse transcriptase or integrase activity based on structural analogy with known lignan antivirals, though specific enzymatic inhibition constants have not been published. Antimicrobial constituents—including terpenoids and saponins—are thought to intercalate into microbial phospholipid bilayers, increasing membrane permeability and leading to loss of cytoplasmic contents, consistent with the broad-spectrum activity observed across gram-positive bacteria, gram-negative bacteria, and fungi.
Clinical Evidence
No registered or published human clinical trials for Justicia gendarussa could be identified in the available scientific literature as of the knowledge cutoff. Animal model outcomes—particularly the 73.71% bilirubin reduction at 300 mg/kg for hepatoprotection—offer preliminary benchmarks but cannot be directly extrapolated to human therapeutic doses due to the absence of bioavailability and pharmacokinetic data. In vitro antimicrobial and anti-inflammatory studies provide mechanistic corroboration for traditional Jamu applications but do not constitute clinical evidence of efficacy or safety in humans. Confidence in any clinical recommendation is currently very low, and the ingredient should be regarded as a candidate for Phase I safety and bioavailability investigation rather than an evidence-based supplement.
Safety & Interactions
Systematic human safety data for Justicia gendarussa are absent; available in vivo evidence from rat studies reports no overt signs of acute toxicity at doses up to 500 mg/kg, but no formal LD50 determination, subchronic toxicity, or genotoxicity study has been published. High concentrations of tannins and polyphenols in the leaf extracts may theoretically cause gastrointestinal irritation, constipation, or impaired iron absorption with prolonged high-dose use, by analogy with other tannin-rich botanicals—though this has not been confirmed experimentally for this species. The historical use as a male contraceptive in Papua New Guinea raises unresolved questions about reproductive toxicity and hormonal modulation that have not been adequately investigated in controlled studies; use during pregnancy and lactation cannot be considered safe in the absence of teratogenicity data. Potential interactions with hepatically metabolized drugs (CYP450 substrates) are plausible given the high flavonoid load, particularly quercetin's known inhibitory effects on CYP3A4 and P-glycoprotein, though no drug interaction studies specific to this plant have been conducted.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Justicia gendarussa Burm.f.GandarussaWillow-leaved JusticiaGendarussa vulgaris NeesAdhatoda gendarussaMinyak Bumi (Indonesian regional)
Frequently Asked Questions
What is Justicia gendarussa used for in traditional medicine?
In Indonesian Jamu medicine and across Southeast Asian ethnobotanical traditions, Justicia gendarussa leaves are primarily used as decoctions for rheumatic pain, fever reduction, contusions, and liver complaints. The leaves are also applied topically as poultices for joint inflammation, and historically the plant has been used in Papua New Guinea as a male contraceptive, though none of these uses have been validated by human clinical trials.
What bioactive compounds are found in Justicia gendarussa?
The leaves contain significant concentrations of flavonoids—including quercetin (confirmed by HPLC and NMR), apigenin, and vitexin—alongside tannins, terpenoids, saponins, and high total phenolics measured at 280.41 mg gallic acid equivalents per gram of methanolic extract. The stalk and bark additionally yield justiprocumins A and B, arylnaphthalide lignan glycosides with demonstrated anti-HIV activity in cell-based bioassays, representing a structurally novel class of antiviral compounds.
Is there clinical evidence supporting Justicia gendarussa for liver protection?
Current hepatoprotective evidence is limited to animal studies: a methanolic leaf extract at 300 mg/kg reduced total bilirubin by 73.71% in a rat liver injury model, a result that closely matched the reference drug silymarin (71.64% reduction). No human clinical trials exist, and without established human pharmacokinetics or equivalent dosing data, these findings cannot currently be applied to clinical practice.
What is the safe dosage of Justicia gendarussa?
No standardized human dose has been established for any form of Justicia gendarussa. Animal research has used 150–500 mg/kg body weight of methanolic extract, with optimal hepatoprotective effects at 300 mg/kg, but these figures cannot be directly converted to human doses without bioavailability studies. Traditional Jamu practice employs decoctions of approximately 10–15 g of dried leaf in 300–500 mL of water, but this preparation has not been quantitatively linked to plasma levels or clinical outcomes.
Does Justicia gendarussa interact with any medications?
No formal drug interaction studies have been conducted for Justicia gendarussa; however, the high quercetin content warrants caution, as quercetin is a known inhibitor of CYP3A4 and P-glycoprotein, which could theoretically raise plasma levels of co-administered drugs such as statins, cyclosporine, or certain antivirals. Additionally, high tannin content may reduce absorption of oral iron supplements and potentially bind to and reduce bioavailability of concurrently administered medications, and patients on hepatotoxic or anticoagulant drugs should consult a clinician before use.
How does Justicia gendarussa compare to milk thistle (silymarin) for liver health?
In preclinical studies, methanolic extracts of Justicia gendarussa demonstrated hepatoprotective effects comparable to silymarin, reducing bilirubin levels by 73.71% (total) and 31.70% (direct) at 300 mg/kg in rats with experimentally induced liver injury. Both herbs appear to work through antioxidant and membrane-stabilizing mechanisms, though Justicia gendarussa's polyphenolic and quercetin content provides similar efficacy in animal models. However, direct head-to-head human clinical trials are limited, so equivalence in humans remains to be established.
Is Justicia gendarussa safe to use during pregnancy or while breastfeeding?
There is insufficient clinical safety data on Justicia gendarussa use during pregnancy and lactation, and it is not recommended without professional medical supervision during these periods. Traditional use does not necessarily confirm safety for vulnerable populations, and the herb's polyphenolic compounds and bioactive constituents have not been adequately studied in pregnant or nursing women. Consult a healthcare provider before use if you are pregnant, planning pregnancy, or breastfeeding.
What extraction method or form of Justicia gendarussa provides the best bioavailability?
Methanolic extraction has been shown to be effective at concentrating bioactive compounds, particularly polyphenols and quercetin, which are responsible for hepatoprotective and anti-inflammatory effects. Leaf-based preparations appear to be the primary form studied and used in traditional medicine, though standardized extracts with defined polyphenol or quercetin content would offer more consistent potency. The optimal extraction method and standardization for human supplementation have not been formally established through comparative bioavailability studies.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w gandarussa-justicia-gendarussa-burmf curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
